Freeline Therapeutics Holdings plc Operating Cash Flow
Freeline Therapeutics Holdings plc reported Operating Cash Flow of -$44.39 million for the 9-month period ending 2023-09-30, per its 6-K filed 2023-12-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2023-12-01
- Freeline Therapeutics Holdings plc net cash provided by (used in) operating activities for the quarter ending 2023-09-30 was -$8.67M.
- Freeline Therapeutics Holdings plc net cash provided by (used in) operating activities for the quarter ending 2023-06-30 was -$17.28M.
- Freeline Therapeutics Holdings plc net cash provided by (used in) operating activities for the quarter ending 2023-03-31 was -$18.44M.
- Freeline Therapeutics Holdings plc net cash provided by (used in) operating activities for the quarter ending 2022-12-31 was -$19.85M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2023-09-30 | -$8.67M derived: 6-K 9 month − 6-K 6 month · filed 2023-12-01 | -$25.95M derived: sum of 2 quarters · filed 2023-12-01 | -$44.39M 6-K · filed 2023-12-01 | -$64.24M derived: sum of 4 quarters · filed 2023-12-01 |
| 2023-06-30 | -$17.28M derived: 6-K 6 month − 6-K 3 month · filed 2023-08-15 | -$35.72M 6-K · filed 2023-08-15 | -$55.57M derived: sum of 3 quarters · filed 2023-08-15 | -$70.74M derived: sum of 4 quarters · filed 2023-12-01 |
| 2023-03-31 | -$18.44M 6-K · filed 2023-05-30 | -$38.29M derived: sum of 2 quarters · filed 2023-05-30 | -$53.46M derived: sum of 3 quarters · filed 2023-12-01 | -$70.08M derived: sum of 4 quarters · filed 2023-12-01 |
| 2022-12-31 | -$19.85M derived: 20-F 12 month − 6-K 9 month · filed 2023-04-04 | -$35.02M derived: sum of 2 quarters · filed 2023-12-01 | -$51.64M derived: sum of 3 quarters · filed 2023-12-01 | -$78.22M 20-F · filed 2023-04-04 |
| 2022-09-30 | -$15.17M derived: 6-K 9 month − 6-K 6 month · filed 2023-12-01 | -$31.79M derived: sum of 2 quarters · filed 2023-12-01 | -$58.37M 6-K · filed 2023-12-01 | -$75.66M derived: sum of 4 quarters · filed 2023-12-01 |
| 2022-06-30 | -$16.62M derived: 6-K 6 month − 6-K 3 month · filed 2023-08-15 | -$43.20M 6-K · filed 2023-08-15 | -$60.49M derived: sum of 3 quarters · filed 2023-08-15 | -$83.18M derived: sum of 4 quarters · filed 2023-08-15 |
| 2022-03-31 | -$26.58M 6-K · filed 2023-05-30 | -$43.88M derived: sum of 2 quarters · filed 2023-05-30 | -$66.56M derived: sum of 3 quarters · filed 2023-05-30 | -$99.92M derived: sum of 4 quarters · filed 2023-05-30 |
| 2021-12-31 | -$17.29M derived: 20-F 12 month − 6-K 9 month · filed 2023-04-04 | -$39.98M derived: sum of 2 quarters · filed 2023-04-04 | -$73.33M derived: sum of 3 quarters · filed 2023-04-04 | -$107.56M 20-F · filed 2023-04-04 |
| 2021-09-30 | -$22.68M derived: 6-K 9 month − 6-K 6 month · filed 2022-11-15 | -$56.04M derived: sum of 2 quarters · filed 2022-11-15 | -$90.27M 6-K · filed 2022-11-15 | -$123.50M derived: sum of 4 quarters · filed 2023-04-04 |
| 2021-06-30 | -$33.36M derived: 6-K 6 month − 6-K 3 month · filed 2022-08-09 | -$67.58M 6-K · filed 2022-08-09 | -$100.82M derived: sum of 3 quarters · filed 2023-04-04 | -$131.80M derived: sum of 4 quarters · filed 2023-04-04 |
| 2021-03-31 | -$34.22M 6-K · filed 2022-05-10 | -$67.46M derived: sum of 2 quarters · filed 2023-04-04 | -$98.44M derived: sum of 3 quarters · filed 2023-04-04 | -$111.23M derived: sum of 4 quarters · filed 2023-04-04 |
| 2020-12-31 | -$33.24M derived: 20-F 12 month − 6-K 9 month · filed 2023-04-04 | -$64.22M derived: sum of 2 quarters · filed 2023-04-04 | -$77.01M derived: sum of 3 quarters · filed 2023-04-04 | -$94.97M 20-F · filed 2023-04-04 |
| 2020-09-30 | -$30.98M derived: 6-K 9 month − 6-K 6 month · filed 2021-11-09 | -$43.77M derived: sum of 2 quarters · filed 2021-11-09 | -$61.73M 6-K · filed 2021-11-09 | |
| 2020-06-30 | -$12.79M derived: 6-K 6 month − 6-K 3 month · filed 2021-08-16 | -$30.74M 6-K · filed 2021-08-16 | ||
| 2020-03-31 | -$17.95M 6-K · filed 2021-05-17 | |||
| 2019-12-31 | -$52.32M 20-F · filed 2022-03-31 | |||
| 2019-06-30 | -$31.63M 6-K · filed 2020-10-29 | |||
| 2018-12-31 | -$25.77M 20-F · filed 2021-03-31 |